Athanasios Didangelos

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. They invest in novel science and innovative approaches to bring promising drug candidates to patients and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. Droia has an in-house team of experts and drug development professionals who follow the portfolio companies closely and provide hands-on support. Droia invests in early financing rounds and incubates new companies.